Respiratory Medicine
Volume 103, Issue 8 , Pages 1098-1113 , August 2009

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update

  • Stephen Holgate

      Affiliations

    • Infection, Inflammation and Repair Division, School of Medicine, University of Southampton, D level Centre Block (MP810), Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 (0) 23 8079 6960; fax: +44 (0) 23 8070 1771.
    • ,
  • Roland Buhl

      Affiliations

    • Mainz University Hospital, 55131 Mainz, Germany
    • ,
  • Jean Bousquet

      Affiliations

    • Hôpital Arnaud de Villeneuve, FR-34000 Montpellier, France
    • ,
  • Nicola Smith

      Affiliations

    • Novartis Horsham Research Centre, Horsham, RH12 5AB, UK
    • ,
  • Zoya Panahloo

      Affiliations

    • Novartis Horsham Research Centre, Horsham, RH12 5AB, UK
    • ,
  • Pablo Jimenez

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936-1080, USA

Received 20 October 2008 ,Accepted 12 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(09)00089-4

doi: 10.1016/j.rmed.2009.03.008

Respiratory Medicine
Volume 103, Issue 8 , Pages 1098-1113 , August 2009

Article Tools

* Image Usage & Resolution